SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Charts for Quick CASH $$$

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carlton G Glenn who wrote (8493)10/2/1998 6:27:00 PM
From: scaram(o)uche   of 9262
 
<<Trickle down to third-tier is coming. Watch for some illiquid issues to become liquid?>>

Hey, Carl:

It's still primed. Take a look at BTRN.... trading at a discount to cash. This is the way I described it in the thread here at SI....

"you have (1) Novartis watching them trade at
a MC which is a fraction of what they will pay to access the XenoMune program, and
(2) MEDI watching them trade at a MC which represents only a couple of months of
the royalties that they hope to pay on 507."

Almost totally illiquid, however. No buying interest, and it looks like someone has been forced, on occasion, to bail (including right now, damn it).

There are lots of companies like these..... discounted horrendously relative to the value of their research. The realm of low market cap:book ratios has traditionally been the realm of biotech also-rans, of companies lacking leverage in their business plans. This is no longer true.

Wish our leader was here.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext